SCHEMBL25399541

SCHEMBL25399541

CNc1ncnc(Cl)c1C=CC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.33
ATM Q13315 1/20 0.33
MAP3K7 O43318 1/20 0.33
TAB1 Q15750 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPK1 P28482 1/20 0.33
BLM P54132 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1449735 0.83 L3MBTL1 (0.43) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL1449733 0.83 L3MBTL1 (0.43) L3MBTL1ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL1094509 0.76 PDPK1 (0.34) ALDH1A1SMN1; SMN2PDE4APDE4BPDE4C
SCHEMBL29253838 0.76 L3MBTL1 (0.38) L3MBTL1ALDH1A1SMN1; SMN2GAAMAP3K7
SCHEMBL23326490 0.75 L3MBTL1 (0.42) L3MBTL1ALDH1A1SMN1; SMN2GAAKDM4E
SCHEMBL19422501 0.73 PDPK1 (0.34)
SCHEMBL13949410 0.73 PDPK1 (0.34)
SCHEMBL11913126 0.70 CA12 (0.43) ALDH1A1SMN1; SMN2GAAMAPTMAP3K7
SCHEMBL1440229 0.66 PDPK1 (0.37) ALDH1A1SMN1; SMN2PDE4APDE4BPDE4C
SCHEMBL14782611 0.66 PDPK1 (0.39) L3MBTL1ALDH1A1SMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023178130-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-09-21 WO disclosed